• Published On : Jan-2018 |
  • Pages : 207 Pages |
  • Format :

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy
     2.3. Sleep Aids Market Overview

3. Market View Point
     3.1. Macro-Economic Factors
     3.2. Opportunity Analysis
     3.3. Epidemiology of sleep apnea

4. North America Sleep Aids Market Analysis 2012–2016 and Forecast 2017–2025
     4.1. Introduction
     4.2. Key Regulations
     4.3. Regional Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Trends
     4.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            4.4.1. U.S.
            4.4.2. Canada
     4.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
            4.5.1. U.S.
            4.5.2. Canada
     4.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            4.6.1. Drugs
                     4.6.1.1. Insomnia treatment drugs
                                4.6.1.1.1. Doxepin Hydrochloride
                                4.6.1.1.2. Eszopiclone
                                4.6.1.1.3. Ramelteon
                                4.6.1.1.4. Triazolam
                                4.6.1.1.5. Zaleplon
                                4.6.1.1.6. Quazepam
                                4.6.1.1.7. Others
                     4.6.1.2. Narcolepsy treatment drugs
                                4.6.1.2.1. Modafinil
                                4.6.1.2.2. Sodium oxybate
                                4.6.1.2.3. Armodafinil
                                4.6.1.2.4. Others
            4.6.2. Devices
                     4.6.2.1. CPAP devices
                     4.6.2.2. BiPAP devices
                     4.6.2.3. APAP devices
            4.6.3. Others
                     4.6.3.1. Mattresses and Pillows
                     4.6.3.2. Chin Straps
                     4.6.3.3. Mouth Pieces and Nasal Devices
     4.7. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
            4.7.1. Drugs
                     4.7.1.1. Insomnia treatment drugs
                                4.7.1.1.1. Doxepin Hydrochloride
                                4.7.1.1.2. Eszopiclone
                                4.7.1.1.3. Ramelteon
                                4.7.1.1.4. Triazolam
                                4.7.1.1.5. Zaleplon
                                4.7.1.1.6. Quazepam
                                4.7.1.1.7. Others
                     4.7.1.2. Narcolepsy treatment drugs
                                4.7.1.2.1. Modafinil
                                4.7.1.2.2. Sodium oxybate
                                4.7.1.2.3. Armodafinil
                                4.7.1.2.4. Others
            4.7.2. Devices
                     4.7.2.1. CPAP devices
                     4.7.2.2. BiPAP devices
                     4.7.2.3. APAP devices
            4.7.3. Others
                     4.7.3.1. Mattresses and Pillows
                     4.7.3.2. Chin Straps
                     4.7.3.3. Mouth Pieces and Nasal Devices
     4.8. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
            4.8.1. Insomnia
            4.8.2. Sleep Deprivation
            4.8.3. Narcolepsy
            4.8.4. Sleep Apnea
            4.8.5. Others
     4.9. Market Size (US$ Mn) Forecast By Indication, 2017-2025
            4.9.1. Insomnia
            4.9.2. Sleep Deprivation
            4.9.3. Narcolepsy
            4.9.4. Sleep Apnea
            4.9.5. Others
     4.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            4.10.1. Hospital Pharmacies
            4.10.2. Retail Pharmacies
            4.10.3. e-commerce
            4.10.4. Drug Stores
            4.10.5. Others
     4.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            4.11.1. Hospital Pharmacies
            4.11.2. Retail Pharmacies
            4.11.3. e-commerce
            4.11.4. Drug Stores
            4.11.5. Others
     4.12.Market Attractiveness Analysis
            4.12.1. By Country
            4.12.2. By Product type
            4.12.3. By Indication
            4.12.4. By Distribution Channel
     4.13.Key Representative Market Participants
     4.14.Key Participants Market Presence (Intensity Map)

5. Latin America Sleep Aids Market Analysis 2012–2016 and Forecast 2017–2025
     5.1. Introduction
     5.2. Key Regulations
     5.3. Regional Market Dynamics
            5.3.1. Drivers
            5.3.2. Restraints
            5.3.3. Trends
     5.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            5.4.1. Brazil
            5.4.2. Mexico
            5.4.3. Rest of Latin America
     5.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
            5.5.1. Brazil
            5.5.2. Mexico
            5.5.3. Rest of Latin America
     5.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            5.6.1. Drugs
                     5.6.1.1. Insomnia treatment drugs
                                5.6.1.1.1. Doxepin Hydrochloride
                                5.6.1.1.2. Eszopiclone
                                5.6.1.1.3. Ramelteon
                                5.6.1.1.4. Triazolam
                                5.6.1.1.5. Zaleplon
                                5.6.1.1.6. Quazepam
                                5.6.1.1.7. Others
                     5.6.1.2. Narcolepsy treatment drugs
                                5.6.1.2.1. Modafinil
                                5.6.1.2.2. Sodium oxybate
                                5.6.1.2.3. Armodafinil
                                5.6.1.2.4. Others
            5.6.2. Devices
                     5.6.2.1. CPAP devices
                     5.6.2.2. BiPAP devices
                     5.6.2.3. APAP devices
            5.6.3. Others
                     5.6.3.1. Mattresses and Pillows
                     5.6.3.2. Chin Straps
                     5.6.3.3. Mouth Pieces and Nasal Devices
     5.7. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
            5.7.1. Drugs
                     5.7.1.1. Insomnia treatment drugs
                                5.7.1.1.1. Doxepin Hydrochloride
                                5.7.1.1.2. Eszopiclone
                                5.7.1.1.3. Ramelteon
                                5.7.1.1.4. Triazolam
                                5.7.1.1.5. Zaleplon
                                5.7.1.1.6. Quazepam
                                5.7.1.1.7. Others
                     5.7.1.2. Narcolepsy treatment drugs
                                5.7.1.2.1. Modafinil
                                5.7.1.2.2. Sodium oxybate
                                5.7.1.2.3. Armodafinil
                                5.7.1.2.4. Others
            5.7.2. Devices
                     5.7.2.1. CPAP devices
                     5.7.2.2. BiPAP devices
                     5.7.2.3. APAP devices
            5.7.3. Others
                     5.7.3.1. Mattresses and Pillows
                     5.7.3.2. Chin Straps
                     5.7.3.3. Mouth Pieces and Nasal Devices
     5.8. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
            5.8.1. Insomnia
            5.8.2. Sleep Deprivation
            5.8.3. Narcolepsy
            5.8.4. Sleep Apnea
            5.8.5. Others
     5.9. Market Size (US$ Mn) Forecast By Indication, 2017-2025
            5.9.1. Insomnia
            5.9.2. Sleep Deprivation
            5.9.3. Narcolepsy
            5.9.4. Sleep Apnea
            5.9.5. Others
     5.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            5.10.1. Hospital Pharmacies
            5.10.2. Retail Pharmacies
            5.10.3. e-commerce
            5.10.4. Drug Stores
            5.10.5. Others
     5.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            5.11.1. Hospital Pharmacies
            5.11.2. Retail Pharmacies
            5.11.3. e-commerce
            5.11.4. Drug Stores
            5.11.5. Others
     5.12.Market Attractiveness Analysis
            5.12.1. By Country
            5.12.2. By Product type
            5.12.3. By Indication
            5.12.4. By Distribution Channel
     5.13.Key Representative Market Participants
     5.14.Key Participants Market Presence (Intensity Map)

6. Europe Sleep Aids Market Analysis 2012–2016 and Forecast 2017–2025
     6.1. Introduction
     6.2. Key Regulations
     6.3. Regional Market Dynamics
            6.3.1. Drivers
            6.3.2. Restraints
            6.3.3. Trends
     6.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            6.4.1. Germany
            6.4.2. France
            6.4.3. U.K.
            6.4.4. Spain
            6.4.5. Italy
            6.4.6. Russia
            6.4.7. Poland
            6.4.8. Rest of Europe
     6.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
            6.5.1. Germany
            6.5.2. France
            6.5.3. U.K.
            6.5.4. Spain
            6.5.5. Italy
            6.5.6. Russia
            6.5.7. Poland
            6.5.8. Rest of Europe
     6.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            6.6.1. Drugs
                     6.6.1.1. Insomnia treatment drugs
                                6.6.1.1.1. Doxepin Hydrochloride
                                6.6.1.1.2. Eszopiclone
                                6.6.1.1.3. Ramelteon
                                6.6.1.1.4. Triazolam
                                6.6.1.1.5. Zaleplon
                                6.6.1.1.6. Quazepam
                                6.6.1.1.7. Others
                     6.6.1.2. Narcolepsy treatment drugs
                                6.6.1.2.1. Modafinil
                                6.6.1.2.2. Sodium oxybate
                                6.6.1.2.3. Armodafinil
                                6.6.1.2.4. Others
            6.6.2. Devices
                     6.6.2.1. CPAP devices
                     6.6.2.2. BiPAP devices
                     6.6.2.3. APAP devices
            6.6.3. Others
                     6.6.3.1. Mattresses and Pillows
                     6.6.3.2. Chin Straps
                     6.6.3.3. Mouth Pieces and Nasal Devices
     6.7. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
            6.7.1. Drugs
                     6.7.1.1. Insomnia treatment drugs
                                6.7.1.1.1. Doxepin Hydrochloride
                                6.7.1.1.2. Eszopiclone
                                6.7.1.1.3. Ramelteon
                                6.7.1.1.4. Triazolam
                                6.7.1.1.5. Zaleplon
                                6.7.1.1.6. Quazepam
                                6.7.1.1.7. Others
                     6.7.1.2. Narcolepsy treatment drugs
                                6.7.1.2.1. Modafinil
                                6.7.1.2.2. Sodium oxybate
                                6.7.1.2.3. Armodafinil
                                6.7.1.2.4. Others
            6.7.2. Devices
                     6.7.2.1. CPAP devices
                     6.7.2.2. BiPAP devices
                     6.7.2.3. APAP devices
            6.7.3. Others
                     6.7.3.1. Mattresses and Pillows
                     6.7.3.2. Chin Straps
                     6.7.3.3. Mouth Pieces and Nasal Devices
     6.8. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
            6.8.1. Insomnia
            6.8.2. Sleep Deprivation
            6.8.3. Narcolepsy
            6.8.4. Sleep Apnea
            6.8.5. Others
     6.9. Market Size (US$ Mn) Forecast By Indication, 2017-2025
            6.9.1. Insomnia
            6.9.2. Sleep Deprivation
            6.9.3. Narcolepsy
            6.9.4. Sleep Apnea
            6.9.5. Others
     6.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            6.10.1. Hospital Pharmacies
            6.10.2. Retail Pharmacies
            6.10.3. e-commerce
            6.10.4. Drug Stores
            6.10.5. Others
     6.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            6.11.1. Hospital Pharmacies
            6.11.2. Retail Pharmacies
            6.11.3. e-commerce
            6.11.4. Drug Stores
            6.11.5. Others
     6.12.Market Attractiveness Analysis
            6.12.1. By Country
            6.12.2. By Product type
            6.12.3. By Indication
            6.12.4. By Distribution Channel
     6.13.Key Representative Market Participants
     6.14.Key Participants Market Presence (Intensity Map)

7. Asia Pacific Sleep Aids Market Analysis 2012–2016 and Forecast 2017–2025
     7.1. Introduction
     7.2. Key Regulations
     7.3. Regional Market Dynamics
            7.3.1. Drivers
            7.3.2. Restraints
            7.3.3. Trends
     7.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            7.4.1. China
            7.4.2. India
            7.4.3. Japan
            7.4.4. Australia and New Zealand
            7.4.5. ASEAN
            7.4.6. Rest of Asia Pacific
     7.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
            7.5.1. China
            7.5.2. India
            7.5.3. Japan
            7.5.4. Australia and New Zealand
            7.5.5. ASEAN
            7.5.6. Rest of Asia Pacific
     7.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            7.6.1. Drugs
                     7.6.1.1. Insomnia treatment drugs
                                7.6.1.1.1. Doxepin Hydrochloride
                                7.6.1.1.2. Eszopiclone
                                7.6.1.1.3. Ramelteon
                                7.6.1.1.4. Triazolam
                                7.6.1.1.5. Zaleplon
                                7.6.1.1.6. Quazepam
                                7.6.1.1.7. Others
                     7.6.1.2. Narcolepsy treatment drugs
                                7.6.1.2.1. Modafinil
                                7.6.1.2.2. Sodium oxybate
                                7.6.1.2.3. Armodafinil
                                7.6.1.2.4. Others
            7.6.2. Devices
                     7.6.2.1. CPAP devices
                     7.6.2.2. BiPAP devices
                     7.6.2.3. APAP devices
            7.6.3. Others
                     7.6.3.1. Mattresses and Pillows
                     7.6.3.2. Chin Straps
                     7.6.3.3. Mouth Pieces and Nasal Devices
     7.7. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
            7.7.1. Drugs
                     7.7.1.1. Insomnia treatment drugs
                                7.7.1.1.1. Doxepin Hydrochloride
                                7.7.1.1.2. Eszopiclone
                                7.7.1.1.3. Ramelteon
                                7.7.1.1.4. Triazolam
                                7.7.1.1.5. Zaleplon
                                7.7.1.1.6. Quazepam
                                7.7.1.1.7. Others
                     7.7.1.2. Narcolepsy treatment drugs
                                7.7.1.2.1. Modafinil
                                7.7.1.2.2. Sodium oxybate
                                7.7.1.2.3. Armodafinil
                                7.7.1.2.4. Others
            7.7.2. Devices
                     7.7.2.1. CPAP devices
                     7.7.2.2. BiPAP devices
                     7.7.2.3. APAP devices
            7.7.3. Others
                     7.7.3.1. Mattresses and Pillows
                     7.7.3.2. Chin Straps
                     7.7.3.3. Mouth Pieces and Nasal Devices
     7.8. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
            7.8.1. Insomnia
            7.8.2. Sleep Deprivation
            7.8.3. Narcolepsy
            7.8.4. Sleep Apnea
            7.8.5. Others
     7.9. Market Size (US$ Mn) Forecast By Indication, 2017-2025
            7.9.1. Insomnia
            7.9.2. Sleep Deprivation
            7.9.3. Narcolepsy
            7.9.4. Sleep Apnea
            7.9.5. Others
     7.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            7.10.1. Hospital Pharmacies
            7.10.2. Retail Pharmacies
            7.10.3. e-commerce
            7.10.4. Drug Stores
            7.10.5. Others
     7.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            7.11.1. Hospital Pharmacies
            7.11.2. Retail Pharmacies
            7.11.3. e-commerce
            7.11.4. Drug Stores
            7.11.5. Others
     7.12.Market Attractiveness Analysis
            7.12.1. By Country
            7.12.2. By Product type
            7.12.3. By Indication
            7.12.4. By Distribution Channel
     7.13.Key Representative Market Participants
     7.14.Key Participants Market Presence (Intensity Map)

8. MEA Sleep Aids Market Analysis 2012–2016 and Forecast 2017–2025
     8.1. Introduction
     8.2. Key Regulations
     8.3. Regional Market Dynamics
            8.3.1. Drivers
            8.3.2. Restraints
            8.3.3. Trends
     8.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
            8.4.1. GCC Countries
            8.4.2. South Africa
            8.4.3. Rest of MEA
     8.5. Market Size (US$ Mn) Forecast By Country, , 2017–2025
            8.5.1. GCC Countries
            8.5.2. South Africa
            8.5.3. Rest of MEA
     8.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            8.6.1. Drugs
                     8.6.1.1. Insomnia treatment drugs
                                8.6.1.1.1. Doxepin Hydrochloride
                                8.6.1.1.2. Eszopiclone
                                8.6.1.1.3. Ramelteon
                                8.6.1.1.4. Triazolam
                                8.6.1.1.5. Zaleplon
                                8.6.1.1.6. Quazepam
                                8.6.1.1.7. Others
                     8.6.1.2. Narcolepsy treatment drugs
                                8.6.1.2.1. Modafinil
                                8.6.1.2.2. Sodium oxybate
                                8.6.1.2.3. Armodafinil
                                8.6.1.2.4. Others
            8.6.2. Devices
                     8.6.2.1. CPAP devices
                     8.6.2.2. BiPAP devices
                     8.6.2.3. APAP devices
            8.6.3. Others
                     8.6.3.1. Mattresses and Pillows
                     8.6.3.2. Chin Straps
                     8.6.3.3. Mouth Pieces and Nasal Devices
     8.7. Market Size (US$ Mn) Forecast By Product Type, 2017–2025
            8.7.1. Drugs
                     8.7.1.1. Insomnia treatment drugs
                                8.7.1.1.1. Doxepin Hydrochloride
                                8.7.1.1.2. Eszopiclone
                                8.7.1.1.3. Ramelteon
                                8.7.1.1.4. Triazolam
                                8.7.1.1.5. Zaleplon
                                8.7.1.1.6. Quazepam
                                8.7.1.1.7. Others
                     8.7.1.2. Narcolepsy treatment drugs
                                8.7.1.2.1. Modafinil
                                8.7.1.2.2. Sodium oxybate
                                8.7.1.2.3. Armodafinil
                                8.7.1.2.4. Others
            8.7.2. Devices
                     8.7.2.1. CPAP devices
                     8.7.2.2. BiPAP devices
                     8.7.2.3. APAP devices
            8.7.3. Others
                     8.7.3.1. Mattresses and Pillows
                     8.7.3.2. Chin Straps
                     8.7.3.3. Mouth Pieces and Nasal Devices
     8.8. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
            8.8.1. Insomnia
            8.8.2. Sleep Deprivation
            8.8.3. Narcolepsy
            8.8.4. Sleep Apnea
            8.8.5. Others
     8.9. Market Size (US$ Mn) Forecast By Indication, 2017-2025
            8.9.1. Insomnia
            8.9.2. Sleep Deprivation
            8.9.3. Narcolepsy
            8.9.4. Sleep Apnea
            8.9.5. Others
     8.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            8.10.1. Hospital Pharmacies
            8.10.2. Retail Pharmacies
            8.10.3. e-commerce
            8.10.4. Drug Stores
            8.10.5. Others
     8.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            8.11.1. Hospital Pharmacies
            8.11.2. Retail Pharmacies
            8.11.3. e-commerce
            8.11.4. Drug Stores
            8.11.5. Others
     8.12.Market Attractiveness Analysis
            8.12.1. By Country
            8.12.2. By Product type
            8.12.3. By Indication
            8.12.4. By Distribution Channel
     8.13.Key Representative Market Participants
     8.14.Key Participants Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape
     11.1.Insomnia Brand Share Analysis
     11.2.Competition Intensity Mapping By Market Taxonomy
     11.3.Competition Dashboard
     11.4.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
            11.4.1. ResMed Inc.
            11.4.2. Koninklijke Philips N.V.
            11.4.3. Merck & Co. Inc.
            11.4.4. Drive DeVilbiss Healthcare LLC
            11.4.5. GlaxoSmithKline Plc.
            11.4.6. Fisher & Paykel Healthcare Limited
            11.4.7. Sanofi SA
            11.4.8. Pfizer Inc.

12. Global Sleep Aids Market Analysis 2012–2016 and Forecast 2017–2025, By Region
     12.1.Introduction / Key Findings
     12.2.Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
            12.2.1. North America
            12.2.2. Latin America
            12.2.3. Europe
            12.2.4. Asia Pacific
            12.2.5. MEA
     12.3.Market Size (US$ Mn) Forecast By Region, 2017-2025
            12.3.1. North America
            12.3.2. Latin America
            12.3.3. Europe
            12.3.4. Asia Pacific
            12.3.5. MEA
     12.4.Market Attractiveness Analysis By Region

13. Global Sleep Aids Market Analysis 2012–2016 and Forecast 2017–2025, By Product Type
     13.1.Introduction
     13.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016
            13.2.1. Drugs
                     13.2.1.1. Insomnia treatment drugs
                                13.2.1.1.1. Doxepin Hydrochloride
                                13.2.1.1.2. Eszopiclone
                                13.2.1.1.3. Ramelteon
                                13.2.1.1.4. Triazolam
                                13.2.1.1.5. Zaleplon
                                13.2.1.1.6. Quazepam
                                13.2.1.1.7. Others
                     13.2.1.2. Narcolepsy treatment drugs
                                13.2.1.2.1. Modafinil
                                13.2.1.2.2. Sodium oxybate
                                13.2.1.2.3. Armodafinil
                                13.2.1.2.4. Others
            13.2.2. Devices
                     13.2.2.1. CPAP devices
                     13.2.2.2. BiPAP devices
                     13.2.2.3. APAP devices
            13.2.3. Others
                     13.2.3.1. Mattresses and Pillows
                     13.2.3.2. Chin Straps
                     13.2.3.3. Mouth Pieces and Nasal Devices
     13.3.Market Size (US$ Mn) Forecast By Product Type, 2017–2025
            13.3.1. Drugs
                     13.3.1.1. Insomnia treatment drugs
                                13.3.1.1.1. Doxepin Hydrochloride
                                13.3.1.1.2. Eszopiclone
                                13.3.1.1.3. Ramelteon
                                13.3.1.1.4. Triazolam
                                13.3.1.1.5. Zaleplon
                                13.3.1.1.6. Quazepam
                                13.3.1.1.7. Others
                     13.3.1.2. Narcolepsy treatment drugs
                                13.3.1.2.1. Modafinil
                                13.3.1.2.2. Sodium oxybate
                                13.3.1.2.3. Armodafinil
                                13.3.1.2.4. Others
            13.3.2. Devices
                     13.3.2.1. CPAP devices
                     13.3.2.2. BiPAP devices
                     13.3.2.3. APAP devices
            13.3.3. Others
                     13.3.3.1. Mattresses and Pillows
                     13.3.3.2. Chin Straps
                     13.3.3.3. Mouth Pieces and Nasal Devices
     13.4.Key Trends / Developments
     13.5.Market Attractiveness Analysis By Product Type

14. Global Sleep Aids Market Analysis 2012–2016 and Forecast 2017–2025, By Indication
     14.1.Introduction
     14.2.Historical Market Size (US$ Mn) Analysis By Indication, 2012-2016
            14.2.1. Insomnia
            14.2.2. Sleep Deprivation
            14.2.3. Narcolepsy
            14.2.4. Sleep Apnea
            14.2.5. Others
     14.3.Market Size (US$ Mn) Forecast By Indication, 2017-2025
            14.3.1. Insomnia
            14.3.2. Sleep Deprivation
            14.3.3. Narcolepsy
            14.3.4. Sleep Apnea
            14.3.5. Others
     14.4.Key Trends / Developments
     14.5.Market Attractiveness Analysis By Indication

15. Global Sleep Aids Market Analysis 2012–2016 and Forecast 2017–2025, By Distribution Channel 
     15.1.Introduction
     15.2.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016
            15.2.1. Hospital Pharmacies
            15.2.2. Retail Pharmacies
            15.2.3. e-commerce
            15.2.4. Drug Stores
            15.2.5. Others
     15.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2025
            15.3.1. Hospital Pharmacies
            15.3.2. Retail Pharmacies
            15.3.3. e-commerce
            15.3.4. Drug Stores
            15.3.5. Others
     15.4.Key Trends / Developments
     15.5.Market Attractiveness Analysis By Distribution Channel

16. Global Market Analysis 2012–2016 and Forecast 2017–2025
     16.1.Market Size and Y-o-Y Growth
     16.2.Absolute $ Opportunity

17. Research Methodology


List of Tables

Table 1: North America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 2: North America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 3: North America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 4: North America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 5: North America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
Table 6: Latin America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 7: Latin America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 8: Latin America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 9: Latin America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 10: Latin America Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
Table 11: Europe Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 12: Europe Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 13: Europe Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 14: Europe Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 15: Europe Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
Table 16: Asia Pacific Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 17: Asia Pacific Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 18: Asia Pacific Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 19: Asia Pacific Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 20: Asia Pacific Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
Table 21: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 22: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 23: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 23: Global Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 24: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 25: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
Table 26: Global Sleep Aids Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region 
Table 27: Global Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 28: MEA Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Indication
Table 29: Global Sleep Aids Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel


List of Figures

Figure 01: Sleep Aids Market Value Share By Product Type (2017)
Figure 02: Sleep Aids Market Value Share By Indication (2017)
Figure 03: Sleep Aids Market Value Share By Distribution Channel (2017)
Figure 04: Sleep Aids Market Value Share By Region (2017)
Figure 05: Global Sleep Aids Market Value (US$ Mn) Forecast 2017 and 2025
Figure 06: Sleep Aids Market Split By Product Type (2017)
Figure 07: Sleep Aids Market Split By Indication (2017)
Figure 08: Sleep Aids Market Split By Distribution Channel (2017)
Figure 09: Sleep Aids Market Split By Country (2017)
Figure 10: Percentage of adults aged 20 and over using prescription sleep aids, by age: United States, 2005–2010
Figure 11: North America Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 12: North America Sleep Aids Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 13: U.S. Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 14: U.S. Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 15: Canada Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 16: Canada Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 17: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Drugs
Figure 18: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Drugs
Figure 19: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Devices
Figure 20: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Devices
Figure 21: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Others
Figure 22: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Others
Figure 23: North America Sleep Aids Market Attractiveness Analysis, By Product Type 
Figure 24: North America Sleep Aids Market Attractiveness Analysis, By Indication
Figure 25: North America Sleep Aids Market Attractiveness Analysis, By Distribution Channel 
Figure 26: North America Sleep Aids Market Attractiveness Analysis, By Country
Figure 27: Sleep Aids Market Split By Product Type (2017)
Figure 28: Sleep Aids Market Split By Indication (2017)
Figure 29: Sleep Aids Market Split By Distribution Channel (2017)
Figure 30: Sleep Aids Market Split By Country (2017)
Figure 31: Latin America Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 32: Latin America Sleep Aids Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 33: Brazil Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 34: Brazil Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 35: Mexico Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 36: Mexico Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 37: Rest of Latin America Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 38: Rest of Latin America Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 39: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Drugs
Figure 40: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Drugs
Figure 41: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Devices
Figure 42: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Devices
Figure 43: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Others
Figure 44: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Others
Figure 45: Latin America Sleep Aids Market Attractiveness Analysis, By Product Type 
Figure 46: Latin America Sleep Aids Market Attractiveness Analysis, By Indication
Figure 47: Latin America Sleep Aids Market Attractiveness Analysis, By Distribution Channel 
Figure 48: Latin America Sleep Aids Market Attractiveness Analysis, By Country
Figure 49: Sleep Aids Market Split By Product Type (2017)
Figure 50: Sleep Aids Market Split By Indication (2017)
Figure 51: Sleep Aids Market Split By Distribution Channel (2017)
Figure 52: Sleep Aids Market Split By Country (2017)
Figure 53: Europe Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 54: Europe Sleep Aids Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 55: Germany Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 56: Germany Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 57: UK Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 58: UK Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 59: France Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 60: France Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 61: Italy Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 62: Italy Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 63: Spain Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 64: Spain Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 65: Russia Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 66: Russia Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 67: Poland Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 68: Poland Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 69: Rest of Europe Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 70: Rest of Europe Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 71: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Drugs
Figure 72: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Drugs
Figure 73: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Devices
Figure 74: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Devices
Figure 75: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Others
Figure 76: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Others
Figure 77: Europe Sleep Aids Market Attractiveness Analysis, By Product Type 
Figure 78: Europe Sleep Aids Market Attractiveness Analysis, By Indication
Figure 79: Europe Sleep Aids Market Attractiveness Analysis, By Distribution Channel 
Figure 80: Europe Sleep Aids Market Attractiveness Analysis, By Country
Figure 81: Sleep Aids Market Split By Product Type (2017)
Figure 82: Sleep Aids Market Split By Indication (2017)
Figure 83: Sleep Aids Market Split By Distribution Channel (2017)
Figure 84: Sleep Aids Market Split By Country (2017)
Figure 85: Asia Pacific Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 86: Asia Pacific Sleep Aids Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 87: Japan Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 88: Japan Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 89: India Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 90: India Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 91: China Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 92: China Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 93: Australia And New Zealand Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 94: Australia And New Zealand Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 95: ASEAN Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 96: ASEAN Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 97: Rest of Asia Pacific Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 98: Rest of Asia Pacific Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 99: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Drugs
Figure 100: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Drugs
Figure 101: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Devices
Figure 102: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Devices
Figure 103: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Others
Figure 104: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Others
Figure 105: Asia Pacific Sleep Aids Market Attractiveness Analysis, By Product Type 
Figure 106: Asia Pacific Sleep Aids Market Attractiveness Analysis, By Indication
Figure 107: Asia Pacific Sleep Aids Market Attractiveness Analysis, By Distribution Channel 
Figure 108: Asia Pacific Sleep Aids Market Attractiveness Analysis, By Country
Figure 109: Sleep Aids Market Split By Product Type (2017)
Figure 110: Sleep Aids Market Split By Indication (2017)
Figure 111: Sleep Aids Market Split By Distribution Channel (2017)
Figure 112 Sleep Aids Market Split By Country (2017)
Figure 113: MEA Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 114: MEA Sleep Aids Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 115: GCC Countries Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 116: GCC Countries Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 117: South Africa Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 118: South Africa Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 119: Rest of MEA Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016
Figure 120: Rest of MEA Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 121: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Drugs
Figure 122: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Drugs
Figure 123: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Devices
Figure 124: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Devices
Figure 125: Sleep Aids Market Size (US$ Mn) Analysis, 2012–2016, By Others
Figure 126: Sleep Aids Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025, By Others
Figure 127: MEA Sleep Aids Market Attractiveness Analysis, By Product Type 
Figure 128: MEA Sleep Aids Market Attractiveness Analysis, By Indication
Figure 129: MEA Sleep Aids Market Attractiveness Analysis, By Distribution Channel 
Figure 130: MEA Sleep Aids Market Attractiveness Analysis, By Country
Figure 131: Global Sleep Aids Market Share Analysis (%) By Region, 2017 & 2025
Figure 132: Global Sleep Aids Market Y-o-Y Growth (%) By Region, 2016–2025
Figure 133: Global Sleep Aids Market Attractiveness Analysis By Region, 2017–2025
Figure 134: Global Sleep Aids Market Share Analysis (%) By Product Type, 2017 & 2025
Figure 135: Global Sleep Aids Market Y-o-Y Growth (%) By Product Type, 2016–2025
Figure 136: Global Sleep Aids Market Attractiveness Analysis By Product Type , 2017–2025
Figure 137: Global Sleep Aids Market Share Analysis (%) By Indication, 2017 & 2025
Figure 138: Global Sleep Aids Market Y-o-Y Growth (%) By Indication, 2016–2025
Figure 139: Global Sleep Aids Market Attractiveness Analysis By Indication, 2017–2025
Figure 140: Global Sleep Aids Market Share Analysis (%) By Distribution Channel, 2017 & 2025
Figure 141: Global Sleep Aids Market Y-o-Y Growth (%) By Distribution Channel, 2016–2025
Figure 142: Global Sleep Aids Market Attractiveness Analysis By Distribution Channel, 2017–2025
Figure 143: Global Sleep Aids Market Value Analysis and Forecast, 2016–2025 (US$ Mn)